Clinical Trial Update: SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled multicenter trial evaluating a skin toxicity treatment in colorectal carcinoma patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma

Snippet

Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Conditions: Colorectal Carcinoma | Phase 2 | Status: TERMINATED